By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Probiodrug AG 

Weinbergweg 22

Halle (Saale)    D-06120  Germany
Phone: 49-345-5559900 Fax: 49-345-5559901


SEARCH JOBS








Company News
Probiodrug AG Release: Innovative Phase II Study Design Of Glutaminylcyclase Inhibitor PQ91 In Early Alzheimer’s Disease 12/8/2016 10:59:10 AM
Probiodrug AG Release: Amyloid-beta (Abeta) Aggregate-Clearing By The Murine Anti-Pyroglutamate-3 Abeta IgG2a Monoclonal Antibody PBD-C06 With And Without A Complement Mutation In An Alzheimer’s Mouse Model 11/16/2016 10:01:46 AM
Probiodrug AG Reports Third Quarter 2016 Business Update 11/10/2016 2:40:52 PM
Probiodrug AG Release: Combination Therapy With Glutaminyl Cyclase (QC) Inhibitor PQ912 And pGlu-Abeta Specific Antibody PBD-C06 Shows Clear Additive Effects In Reducing pGlu-Abeta As Well As Abeta In Alzheimer-Mouse Model 9/13/2016 9:20:21 AM
Promising New Findings For Probiodrug AG's Glutaminyl Cyclase - Inhibitor In An Inflammation Animal Model 9/7/2016 12:48:55 PM
Probiodrug AG To Publish First Half 2016 Results On 30 August 2016 8/23/2016 8:57:58 AM
Probiodrug AG Announces Changes ToThe Supervisory Board And Executive Management 8/12/2016 8:09:07 AM
Probiodrug AG And Crossbeta Biosciences Enter Into A Strategic Partnership In The Field Of Alzheimer’s Disease Biomarkers 6/30/2016 11:47:41 AM
Probiodrug AG Announces Results Of Chronic Toxicology Studies With PQ912, Its "First In Class" Glutaminyl Cyclase (QC) Inhibitor For The Treatment Of Alzheimer’s Disease 4/4/2016 9:21:02 AM
Probiodrug AG Appoints Mark Booth As Chief Business Officer 3/23/2016 8:56:33 AM
123456
//-->